Severe hypotension associated with α blocker tamsulosin.
Benign prostatic hyperplasia is the main cause of lower urinary tract symptoms in men—voiding, storage, or post-micturition symptoms are common to several genitourinary and neurological diseases. Men with these symptoms experience decreased quality of life, depression, and loss of productivity. The...
- Autores:
-
Ramírez Escobar, Jorge Hernán
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2013
- Institución:
- Universidad ICESI
- Repositorio:
- Repositorio ICESI
- Idioma:
- eng
- OAI Identifier:
- oai:repository.icesi.edu.co:10906/78488
- Acceso en línea:
- http://www.scopus.com/inward/record.url?eid=2-s2.0-84888183836&partnerID=tZOtx3y1
http://www.bmj.com/content/bmj/347/bmj.f6492.full.pdf
http://hdl.handle.net/10906/78488
- Palabra clave:
- Rights
- openAccess
- License
- https://creativecommons.org/licenses/by-nc-nd/4.0/
| Summary: | Benign prostatic hyperplasia is the main cause of lower urinary tract symptoms in men—voiding, storage, or post-micturition symptoms are common to several genitourinary and neurological diseases. Men with these symptoms experience decreased quality of life, depression, and loss of productivity. The prevalence of these symptoms varies from 15% to 60% of men over 40 years of age.1 Worldwide, population ageing is contributing to the increasing burden of benign prostatic hyperplasia. This is accompanied by increasing healthcare costs owing to the growing list of treatment options. The study by Bird and colleagues (doi:10.1136/bmj. f6320) evaluates the safety of one such treatment |
|---|